For 8 wk 5 groups of 10 men each were given 0.5 &/day DL-methionine, 150 g Se/day as sodium selenite with or without methionine or 150 Jg Se/day as selenomethionine with or without methionine. Twenty subjects received placebo as contros. Initially plasma Se rose more rapidly than RBC Se. Increases in Se levels were significantly greater with selenomethionine than with the selenite supplement. In the placebo and methionine supplemented groups neither plasma nor RBC Se varied significantly over the course of the study. Supplementation with selenium resulted in marked increases in plasma and RBC GSH-Px within 2 and 4 wk, respectively. Plasma and RBC GSH-Px activity did not differ significantly between Se-supplemented groups. These studies suggest that selenomethionine-Se was more effective in raising plasma and RBC Se than was selenite-Se. Methionine supplements may increase the bioavailability of selenium in severely deficient subjects.
Introduction
of cancer associated with low levels of environmental Se (5, 6). Selenium compounds The nutritional essentiality of selenium in added to the diet or water have now been humans was established in 1979 when ben-shown to be effective inhibitors of chemical eficial responses to Se supplementation were carcinogenesis in different experimental aniobserved in certain patients living in low-Se mals (6, 7) . Some scientists suggest that Se areas of New Zealand and the People's Re-may possess cancer-protecting properties in public of China. Chinese scientists reported the human (6, 8) . Selenium may be involved a dramatic reduction in the incidence of in the conjugation and detoxification of heavy Keshan disease-an endemic cardiomyopa-metals and the resulting lowered body and thy-after an intervention trial with sodium tissue levels of Se have been proposed as a selenite (1, 2) . The New Zealand work implicating Se in human nutrition concerned a patient with muscle cramps who had been 'From the Cancer Institute (XL, HW, JX. XL, CQ.
giventota parnterl nutitio for29 ~ YF, JL, XL), Chinese Academy of Medical Sciences.
given total parenteral nutrition for 29 days Beijing. PRC; Endemic Disease Institute (CY, YL, QW, because of complications following abdominal JG). Weichang. PRC; and Department of Food and surgery (3) . When 100 ptg of Se as seleno-Nutrition (BJS, JES, SPY), Texas Tech University, Lubmethionine was added to the daily intrave-bock, TX. This study had two components.
Sunde and coworkers reported the biopo-V) Survey study. The purpose of the survey study was tency of selenomethionine to be decreased in to determine adequate dosage of Se supplementation for a diet low in methionine especially when fed the treatment study. The 15 adults who participated in at levels near the Se requirement (9) . These this study were divided into 3 groups of 3 men and 2 women each. Group I received a placebo while groups results suggest that adequate dietary methio-2 and 3 received 50 or 150 pg Se as Na 2 SeO, daily. nine is required for optimal utilization of Se Selenium levels and glutathione peroxidase (GSH-Px) in foodstuffs of plant origin since selenome-activity in plasma and RBC were measured on days 0, thionine is presumably a major form of plant IS and 30 of the Se supplementation period. Se. Since the difference between beneficial 2) Treatment study. This study was designed to as.
is certain the effect of Se supplements on the Se status of and toxic levels for Se in human beings is residents in a low-Se area. The 70 men in this study small, the Se status in a healthy population were separated into 6 treatment groups as shown in and the effectiveness of Se supplements for 
Diets
AU subjects ate setf-selected diets They were instructed to take only locally produced food. No liver, kidney, or Methods fish were eaten during the experimental period.
Subjects
Selenium supplementation Six women and 79 men of naturally low-Se status
The sodium selenite and Semet supplements were [red blood cells (RBC) Se less than 110 ng/g Hb and compounded in lactose and starch (Beijing Pharmaceu- 58.0 ± 1.9 91.9 ± 6.9 14.6 ± 0.7 * Mean ± SEM. ticals, Beijing, PRC). Placebo tablets contained only assay) and analyzed immediately. Absorbance at 340 nm these two items and were not distinguishable from Se was recorded. The reaction was followed for 2-4 min. supplements. Chemical analysis showed that the placebo The nonenzymic rate of NADPH oxidation was subproducts contributed negligible quantities of Se to the tracted from each assay. One unit of activity was defined total daily intake. Six local cadres who were especially as I rmol NADPH oxidized/min and the results expressed trained took charge of the daily supplements. The subjects as units/mil plasma or units/g Hb for RBC. were instructed to take the placebo or supplements in the morning.
Chemical reagents
DL-Me~hionine supplementation
Selenomethionine, DL-methionine, NADPH, glutathi-DL-Afetluoninesuxpplementatt~ion one, glutathbione reductase, sodium azide. and KCN were The amount of daily Met supplementation was 0.5 g.
purchased from Sigma Chemical Co St Louis, MO. The The DL-methionine used in this study contained 0.00263 remaining reagents were from Beijing Chemical Reagent ppm Se and thus provided only 0.0013 msg of Se a day Co, Beijing PRC. to the methionine-supplemented subjects. Plasma and RBC Se level remained quite steady over the Met Statistical analysis supplement period.
The experimental data were subjected to one-way
Blood sample preparation and analyses analysis of variance and compared by Duncan's multiple range test (2 3). Fasting blood samples were drawn by venipuncture early in the morning. Hemoglobins were determined on an aliquot of whole blood. Six ml of blood was treated Results with 0.1 ml of 10.0% potassium oxalate and centrifuged. groups (Figs I and 2 ). Plasma Se initially wk 8. With methionine supplementation, rose more rapidly than erythrocyte Se and significant increases compared to initial levels differences between the groups became ob-were observed in plasma GSH-Px activity at vious after only 2 wk (Fig 1) . After 8 wk 2, 4, 6 and 8 wk (p < 0.05). GSH-Px activity increases in both plasma and erythrocyte Se in RBC increased with the Met supplemenwere greater after Semet than after Na 2 SeO 3 tation at 4, 6 and 8 wk (p < 0.01). However, with or without Met supplements. Plasma Se the levels of plasma and RBC GSH-Px atreached a plateau with Na 2 SeO 3 supplemen-tained at the end of 8 wk with Met suppletation at wk 4 and with Na 2 SeO 3 plus Met mentation alone were much lower than with and Semet, at wk 6. With supplements of Se supplementation. GSH-Px activities in Semet plus Met, plasma Se continued to rise plasma and RBC of the placebo group rewith no sign of plateauing at wk 8.
mained constant throughout the dosing peAfter 2 wk of supplementation, erythrocyte nod. Se began to rise and appeared to plateau for The paired correlations between Se level all Se-supplemented groups after 6 wk. Me-and GSH-Px activity in plasma were signifithionine supplementation exhibited no evi-cant either before (r = 0.44 for 100 samples, dent effects in increasing plasma and eryth-p < 0.001) or during the dosing period (r rocyte Se levels in groups given Na 2 SeO 3 or = 0.245 for 76 samples, p < 0.025). Such Semet. Methionine supplementation, how-relationships were not found between Se ever, appeared to delay the plateauing of levels and GSH-Px activities in erythrocytes plasma Se level for groups given Semet or before Se supplementation; but positive corNa 2 SeO 3 and seemed to slow down the in-relations were observed in groups given selcorporation of supplemented selenite-Se into enite or Semet (r = 0.45, n = 78, p < 0.0005, erythrocytes. Plasma and erythrocyte Se levels and r = 0.75, n = 74, p < 0.0005, respecin the placebo and methionine groups re-tively). The regression line for Semet is shown mained quite steady throughout the interven-in Figure 5 . tion period.
Once Se supplementation began, GSH-Px Discussion activities in plasma increased promptly for
The high dose of Se used in this intervenall Se-supplemented groups, GSH-Px activity tion trial was 150 pug/day which is 50 pg doubled or tripled in 2 wk and approached below the upper limit of the estimated safe a plateau at wk 6 for groups given Semet and adequate range for adults established by and Na 2 SeO 3 plus Met (Fig 3) . On the other the US National Research Council (14). Since hand, enzyme activities of groups given the mean daily Se intake for residents of Na 2 SeO 3 and Semet plus Met apparently Molimo ranged from only 5-13 pg (15) the were still increasing at wk 8.
level of Se supplementation was considered Supplementation with Se resulted in sub-safe for this short-term study of adult male stantial increases in erythrocyte GSH-Px ac-subjects with low-Se status. For men the tivities for all Se-supplemented groups at wk minimum daily Met intake is estimated to 4 (Fig 4) . Enzyme activities were similar in be 1.10 g and the safe daily intake is estimated all four groups and continued to rise during at 2.20 g (16) . The average daily intakes of 
Met for adult men in Molimo ranged from
There was a 2-wk delay in the RBC GSH-Px 1.06 to 1.85 B. so for this trial the amount response and a somewhat longer delay in of daily Met supplementation was limited to some groups before the RBC Se levels became 0-5 g. sig~nificantly higher than controls. Our data The data indicated that Se level and GSH-aggree closely with those reported by Steiner Se-rich yeast, but this contradicts a more the mean increases in GSH-Px activities for recent study in which Levander et al (18) the two forms were not significantly different. found only a small increase in plasma GSH-Thomson et al (2 1) and Robinson et al (22) Px activity during Se supplementation to likewise showed that increases in Se concenadult Finnish men. It is possible that this tration in whole blood, erythrocytes, and discrepancy might be related to the extremely plasma were greater after Semet than after low-Se status of our subjects as compared to Na2SeO3. Selenium from (7"Se)selenomethe moderately low-Se status in their study.
thionine was also reported to be more comSince Semet has been identified as a major pletely absorbed by humans than Se from form of Se present in cereals (19, 20) , it (7'Se)-selenite (23, 24) . deserves special comment. Our data showed Supplementation with Semet compared to that Semet was more effective in raising Na2SeO3 produced higher circulating Se levels plasma and RDC Se than was Na2SeO3, but but not greater GSH-Px activity in plasma and erythrocytes. Possible explanations in-GSH-Pz levels in plasma and RBC increased elude: 1) plasma and erythrocyte Se may sharply between 2 and 4 wk and the groups reflect circulating Semet from the supplement were indistinguishable. that has not been incorporated into GSHSunde and coworkers (9) reported that in Px; or 2) Sernet may be better absorbed but rats Semet was more extensively incorporated other factors may prevent Se incorporation into protein when dietary methionine was into GSH-Px. A dose smaller than 150 pug suboptimal making less Se available for GSHof Se/day may be required to actually test Px synthesis. In our studies a similar decrease the bioavailability of selenomethionine vs in biopotency of Semet was not observed in Na 2 SeO 3 in this population. With 150 jg Se, groups given Semet without Met supplements. It is likely that with 150 Ag Se supplements compared to controls. Beilstein and Whanger the daily Met intakes of residents were not noted that a significant amount of GSH-PX low enough to reduce bioavailability of Se activity in a human erythrocyte lysate cofrom selenomethionine to an extent detect-chromatographed with hemoglobin rather able using plasma GSH-Px.
than with Se-dependent GSH-Px. (25) . in our Results based on the RBC GSH-Px assay study, the GSH-Px activity was not chrolikewise showed no evident effects of Met matographed, so it was not possble to detersupplements on the bioavailability of Se from mine whether the methionine supplements either Semet or Na2SeO3 supplements. How-alone increased the Se-dependent or non-Seever, RBC GSH-Px activity of the group dependent GSH-Px: activity. A more likely supplemented only with methionine increased explanation for the increased R8C GSH-Px activity may be that with added methionine to Na 2 SeO 3 produced higher circulating Se there is less incorporation of Semet-Se from levels but not greater GSH-Px activity in food into protein, leaving more Se available plasma and erythrocytes. for GSH-Px synthesis (9) .
3) In subjects receiving no Se supplements, In subjects given Met supplements, plasma RBC GSH-Px increased significantly with Se level appeared to plateau more slowly for Met supplements. A column separation of groups given either Semet or Na 2 SeO 3 . An the GSH-Px from the RBC lysate would be explanation for these results will require fur-necessary to determine whether the Met effect ther study.
is on Se-dependent GSH-Px or on non-SeOur studies performed thus far suggest dependent GSH-Px activity. No long-term that:
significant effects of Met were seen in groups 1) Daily supplementation with 150 pug Se supplemented with either Na 2 SeO 3 and for more than 2 mo may be needed by Semet. residents in a low-Se area, like Molimo, to 4) Selenium concentration and GSH-Px increase plasma and RBC Se and GSH-Px activities in plasma and erythrocytes were activity to the levels of people in a Se-confirmed as sensitive indices of changes in adequate area (Beijing).
Se status in people from an extremely low-2) Supplementation with Semet compared Se area. Plasma Se concentrations and GSH-
